跳至主要内容
临床试验/NCT01449890
NCT01449890已完成不适用

Randomized Trial of E-mail Follow-up Care After Cognitive Behavioural Treatment for Depression

Universitätsklinikum Hamburg-Eppendorf2 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2012年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
92
试验地点
2
主要终点
Measure of the severity of depression - Beck Depression Inventory (BDI- II)

研究概览

简要总结

The primary objective of this study is to test in a randomized effectiveness trial if e-mail delivered cognitive behavioural treatment is an effective follow-up care approach in the treatment of depression under clinically representative conditions.

详细描述

Depression belongs to the most prevalent mental disorders and often goes along with a high burden of disease. Although the efficacy and the effectiveness of psychological treatments for depressive disorders have been demonstrated, there remains the problem of maintaining the benefits achieved during the initial treatment phase. Therefore options of follow-up care have to be considered. Since access to psychotherapeutic treatments is limited and costly, internet-based interventions can offer a feasible opportunity for follow-up care in order to enhance the long-term effectiveness of psychotherapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Depressive disorder: F32.0-F32.2; F33.0-F33.2; F34.1 according to ICD-10
  • Precursory CBT
  • Internet access

排除标准

  • No knowledge of the German language
  • Risk of suicide
  • Acute psychosis or psychotic symptoms
  • Established concurrent in vivo CBT after discharge from inpatient CBT

结局指标

主要结局

Measure of the severity of depression - Beck Depression Inventory (BDI- II)

时间窗: Change in the BDI-II from baseline (beginning of treatment) to follow up (3 months after termination of the follow-up care)

次要结局

  • Depressive relapse/recurrence(Measured at follow up (3 months after termination of the follow-up care))
  • Measure of health related quality of life - SF-8(Change in the SF-8 from baseline (beginning of treatment) to follow up (3 months after termination of the follow-up care)
  • GAD-7(Change in the GAD-7 from baseline (beginning of treatment) to follow up (3 months after termination of the follow-up care))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

PD Dr. phil. Birgit Watzke

Principal Investigator

Universitätsklinikum Hamburg-Eppendorf

研究点 (2)

Loading locations...

相似试验